The short answer: eliminate rework at the decision points

Medical device startups can accelerate product development cycles by identifying the decisions most likely to cause downstream changes and addressing them early. In practice, this means:

• Aligning clinical, commercial, engineering, quality, regulatory, and manufacturing stakeholders around one product definition.
• Translating user needs into measurable system and subsystem requirements.
• Using risk management to determine which technical questions deserve attention first.
• Prototyping high-risk functions before investing in polished production-intent designs.
• Reviewing design-for-manufacturing, assembly, supplier, and tooling assumptions early.
• Building verification protocols and acceptance criteria while requirements are being written.
• Testing usability with representative users before the interface and workflow are difficult to change.
• Maintaining traceability and design documentation throughout development rather than reconstructing it at the end.
• Using experienced external engineering support when internal bandwidth or specialized expertise is limited.

The objective is not to compress every activity into the shortest possible calendar time. The objective is to make each development loop produce reliable information and to discover critical problems while they are still inexpensive to correct.

Why medical device development programs slow down

Most schedule problems originate upstream. A team may believe it is delayed by a difficult prototype, a supplier lead time, or a testing failure, but the underlying issue is often an unresolved requirement or an assumption that was never assigned an owner.

1. The product definition is too vague

Statements such as “easy to use,” “comfortable,” “low cost,” or “works in the clinic” are useful strategic goals but weak engineering requirements. They do not tell a designer what to build or a test engineer what evidence to collect. Ambiguous requirements create multiple interpretations, which increases design churn.

2. Functional groups work in sequence instead of in parallel

When product management defines the device, engineering designs it, quality reviews it later, and manufacturing receives it near the end, each handoff creates an opportunity for discovery and rework. A change to dimensions, materials, software behavior, or assembly method may affect risk analysis, verification, labeling, tooling, supplier qualification, and regulatory documentation.

3. Teams optimize the prototype instead of the decision

A visually impressive prototype can still leave the most important technical uncertainty unresolved. For example, a startup may spend weeks refining the enclosure before confirming that the fluid path, energy transfer, sensor accuracy, tissue interaction, or sterilization approach is feasible. Prototypes should be selected according to the question they need to answer.

4. Quality documentation is postponed

Reconstructing design history, requirement rationale, test evidence, and change decisions near a regulatory milestone is slow and risky. FDA design control expectations require documentation of design activities and objective evidence that the design meets defined requirements. Treating documentation as a parallel workstream reduces the end-of-project scramble. ([fda.gov](https://www.fda.gov/medical-devices/premarket-notification-510k/special-considerations-510ks?utm_source=openai))

5. Human factors and manufacturing constraints arrive too late

A device can perform correctly in a laboratory and still be difficult to use in a clinical environment. Likewise, a prototype can be manufacturable in small quantities but impractical to assemble, inspect, sterilize, package, or scale. Late discovery in either area can force a major redesign.

Build an integrated development operating model

Acceleration begins with the way the startup organizes decisions. A small company does not need a large bureaucracy, but it does need clear ownership, short feedback loops, and a shared view of the program.

Establish a cross-functional core team

At minimum, the core team should connect product or clinical leadership with mechanical or electrical engineering, systems engineering, quality, regulatory, manufacturing, and supply chain perspectives. One person may hold multiple roles, especially in an early-stage company, but each responsibility should still be explicit.

A weekly cross-functional review can focus on decisions rather than status reporting. Useful questions include:

• What changed since the last review?
• Which requirements are still ambiguous?
• Which technical risks could change the architecture?
• What evidence is needed to close the next decision?
• Which supplier, tooling, quality, or regulatory activity could affect the critical path?
• Who owns the decision, and by what date?

Use one integrated program plan

The schedule should connect engineering tasks to quality, regulatory, manufacturing, and commercial milestones. A prototype build is not complete merely because parts exist; it may also require incoming inspection, assembly instructions, configuration control, test fixtures, data collection methods, and a documented purpose for the build.

A65 Consulting provides program management support that includes schedule development, milestone tracking, resource planning, risk identification, and stakeholder communication. These capabilities can help a startup create accountability without building a full internal program management office. Explore A65 Consulting services.

Convert the clinical idea into testable requirements

Strong requirements are one of the most effective schedule-control tools available to a startup. They create a common language between users, designers, testers, quality professionals, and regulatory teams.

Start with user needs and intended use

Document who will use the device, who will be affected by it, where it will be used, what clinical problem it addresses, and what the device is expected to do. Include foreseeable use conditions such as limited visibility, gloves, fluid exposure, time pressure, cleaning, transport, power interruption, or use by personnel with different levels of training.

Decompose needs into measurable requirements

A system requirement should be specific enough to verify. Instead of “the device must provide adequate flow,” define the relevant operating conditions, flow range, accuracy, duration, interfaces, alarms, and allowable variation. Instead of “the handle must be comfortable,” identify measurable ergonomic, force, reach, grip, or usability criteria supported by user research.

Create traceability early

Trace each user need to system requirements, subsystem requirements, design outputs, risk controls, and verification or validation evidence. Traceability exposes gaps early. If a requirement has no planned test, the team may not know how it will demonstrate compliance. If a test has no requirement, the team may be spending time on evidence that does not support a meaningful decision.

A65 Consulting’s systems engineering services include requirements development, system architecture, risk mitigation, traceability, verification and validation protocols, human factors engineering, voice-of-customer research, and root-cause investigation. See the systems engineering capabilities.

Use risk analysis to prioritize engineering work

Risk management accelerates development when it changes what the team does next. It becomes a schedule burden when it is treated as a static document completed for compliance purposes.

ISO 14971 provides the recognized framework for applying risk management to medical devices, while ISO 13485:2016 establishes quality management system requirements specific to medical device organizations. ISO describes risk-based decision-making as an important part of medical device quality management. ([iso.org](https://www.iso.org/iso-13485-medical-devices.html?utm_source=openai))

Prioritize risks that can change the architecture

Early risk reviews should focus on hazards and failure modes that could force a fundamental change. Examples include unacceptable tissue interaction, inadequate structural strength, inability to maintain sterility, unsafe energy delivery, inaccurate measurement, foreseeable misuse, data integrity failures, or an unqualified material in a critical patient-contacting application.

Connect risk controls to design requirements

A risk control should lead to a design feature, protective measure, process control, user instruction, or combination of controls. That control should then appear in the requirements and verification plan. This connection prevents the risk file from becoming disconnected from the actual design.

Update the analysis after meaningful changes

Risk analysis should be revisited after architecture decisions, material substitutions, software changes, supplier changes, adverse test results, new use information, or changes to the intended user population. A living risk process helps the team understand whether a faster design decision creates a new downstream burden.

Prototype to answer decisions, not to create appearances

Different development questions require different prototype strategies. A startup can save time by choosing the simplest prototype that generates credible evidence.

Analytical models can be especially valuable when they reduce unnecessary build-test iterations. A65 Consulting describes using analytical modeling, finite element analysis, prototypes, testing, and iteration in medical device projects such as an endoscopic ultrasonic surgical probe. Review examples of A65 Consulting project work.

Bring manufacturing into the design before design freeze

Design for manufacturing and design for assembly are not end-of-cycle cost exercises. They are methods for preventing a design from becoming trapped between technical feasibility and commercial production.

Review materials and component availability

Confirm whether critical materials, electronic components, adhesives, coatings, packaging materials, and custom parts are available in the required quality and volume. Review lead times, minimum order quantities, lifecycle risks, supplier capabilities, and change-notification practices before the design depends on them.

Design for repeatable assembly

Evaluate part orientation, access, joining methods, inspection points, torque requirements, adhesive cure conditions, error-proofing, operator training, and opportunities for automation. A design that is intuitive to assemble can reduce defects and shorten process development.

Plan tooling and process validation

Identify which characteristics require production tooling, fixtures, gauges, test equipment, or validated processes. If the team waits until after design freeze to consider these needs, tooling and process development can become a new critical path.

Use standard components strategically

Commercially available components can reduce sourcing risk and shorten prototype lead times, but they must still be evaluated for intended use, performance, biocompatibility where applicable, reliability, supply continuity, and regulatory suitability. Customization should be reserved for features that create meaningful clinical, technical, or commercial value.

A65 Consulting supports manufacturing engineering, design-for-manufacturing reviews, process development, and production transition. Learn about manufacturing support.

Run verification continuously instead of saving it for the end

Verification asks whether design outputs meet specified requirements. Validation asks whether the resulting device meets user needs and intended use. Both should influence the development process before the final submission package is assembled.

Write testable protocols alongside requirements

For each important requirement, define the method, equipment, sample configuration, acceptance criteria, environmental conditions, sample size rationale, data analysis approach, and documentation expectations. Early protocol development can reveal requirements that are too vague or tests that are technically impractical.

Test at the lowest useful level

Do not wait for a complete device if a component or subsystem can answer the question. Test materials, interfaces, mechanisms, sensors, software functions, and assemblies as they mature. Early testing reduces the number of unknowns carried into system-level verification.

Control configuration

Test results are only useful when the team knows exactly what was tested. Maintain configuration identification for drawings, software versions, materials, firmware, fixtures, and build records. This practice also supports a credible design history file.

Use simulation carefully

Computational modeling, tolerance analysis, and finite element analysis can help compare concepts and focus physical testing. However, model assumptions, inputs, boundary conditions, validation, and limitations should be documented. Simulation should strengthen an evidence strategy, not replace necessary testing without a defensible rationale.

FDA identifies design controls, design transfer, change control, and design history documentation as important elements of medical device development. ([fda.gov](https://www.fda.gov/medical-devices/premarket-notification-510k/special-considerations-510ks?utm_source=openai))

Include human factors before the design is locked

Human factors engineering helps ensure that intended users can operate the device safely and effectively in the environments where it will actually be used. It should begin with user research and workflow analysis, not with a final-form usability study.

Early activities may include:

• Identifying user groups, use environments, and use-related hazards.
• Mapping critical tasks and likely points of confusion.
• Evaluating controls, displays, connectors, labels, alarms, and physical interfaces.
• Testing early concepts with representative users.
• Designing risk controls that do not rely solely on memory, training, or warnings.
• Documenting the relationship between use-related risks and design changes.

FDA’s May 2026 guidance describes a risk-based framework for human factors information in marketing submissions, including 510(k)s, De Novo requests, PMAs, and HDEs. The guidance is intended to support consistent documentation and efficient review. ([fda.gov](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions?utm_source=openai))

For a startup, the practical implication is straightforward: usability findings should arrive while the team can still change the interface, workflow, or physical form without destabilizing the entire program.

Create regulatory-ready evidence as you go

Regulatory strategy should be established early enough to influence the product definition. The appropriate pathway depends on the device, intended use, classification, predicate or performance comparison where applicable, technology, claims, and available evidence. A regulatory professional should assess the specific product and market before the startup commits to a development plan.

Define the evidence strategy

Map the anticipated submission or market-access route to the evidence the team must generate. Depending on the device, this may include bench performance, electrical safety, electromagnetic compatibility, biocompatibility, sterilization, packaging, shelf life, software, cybersecurity, human factors, animal, or clinical evidence.

Keep design documentation current

Maintain approved requirements, design outputs, reviews, risk records, test protocols, reports, meeting decisions, supplier records, and change assessments in a controlled system. A current record is easier to review, easier to hand off, and easier to defend than a collection of reconstructed files.

Engage quality and regulatory expertise at the right time

Early involvement does not mean every decision requires a lengthy review. It means quality and regulatory considerations are included when they can still influence architecture, claims, materials, testing, and process choices.

A65 Consulting offers quality engineering and regulatory support, including quality management system support, supplier and internal audit assistance, regulatory pathway analysis, submission documentation, responses to regulatory questions, and cross-functional regulatory alignment. Explore quality and regulatory support.

When an external engineering partner can accelerate a startup

Hiring a full internal team may be appropriate as a startup scales, but it is not always the fastest first move. An experienced engineering partner can provide specialized capability, leadership, and execution capacity during the stages when the company needs them most.

Common triggers for external support

• The founder or product leader is carrying technical decisions without a dedicated engineering lead.
• The internal team has strong expertise in one discipline but lacks systems, manufacturing, quality, or regulatory depth.
• A critical prototype, test plan, design review, or manufacturing transfer milestone is approaching.
• The company needs additional engineering capacity without adding permanent headcount.
• Technical debt, incomplete requirements, or unclear ownership is threatening the schedule.
• The startup needs an objective assessment of whether the current design is ready to proceed.

A65 Consulting works with medical device organizations across the product life cycle, from research and conceptualization through product development, manufacturing transfer, and cost optimization. The firm also supports clients that need additional engineering resources or interim engineering leadership. Learn more about A65 Consulting.

The most effective external partner does not create another silo. It integrates with the startup’s existing team, communicates decisions clearly, transfers knowledge, and leaves behind usable requirements, analyses, test evidence, drawings, processes, and documentation.

A practical acceleration roadmap for a medical device startup

Phase 1: Establish the decision framework

1. Define intended use, users, use environments, and initial claims.
2. Identify the likely regulatory pathway and evidence implications.
3. Document the top clinical, technical, manufacturing, and business assumptions.
4. Assign owners for engineering, quality, regulatory, manufacturing, and program decisions.

Phase 2: Reduce the highest-impact uncertainty

1. Develop preliminary system architecture and interface definitions.
2. Start hazard analysis and preliminary risk controls.
3. Rank technical questions by potential impact on safety, architecture, schedule, and cost.
4. Build focused prototypes or analytical models to answer the highest-priority questions.

Phase 3: Convert learning into controlled design

1. Translate validated assumptions into measurable requirements.
2. Create design outputs with appropriate drawings, specifications, software definitions, and assembly information.
3. Review materials, suppliers, tooling, assembly, inspection, packaging, and process constraints.
4. Begin writing verification protocols and acceptance criteria.

Phase 4: Build evidence while iterating

1. Run subsystem and system verification as the design matures.
2. Conduct formative human factors activities with representative users.
3. Update risk analysis after test results and design changes.
4. Maintain traceability, configuration control, design reviews, and design history documentation.

Phase 5: Prepare for transfer and launch

1. Confirm that production specifications reflect the verified design.
2. Complete manufacturing process development, work instructions, inspection methods, and supplier readiness activities.
3. Resolve open risks, test anomalies, and documentation gaps.
4. Conduct a formal launch-readiness review against technical, quality, regulatory, manufacturing, and commercial criteria.

Key takeaways

• Accelerate by reducing rework: The fastest development cycle is usually the one with the fewest late discoveries.
• Integrate functions early: Engineering, quality, regulatory, manufacturing, clinical, and product stakeholders should share decisions before handoffs occur.
• Make requirements measurable: Clear requirements create faster design reviews and more efficient verification.
• Let risk determine priorities: Test the assumptions that could change the architecture or create unacceptable patient or user risk.
• Prototype strategically: Use the simplest credible prototype or analysis that answers the current decision.
• Design for production from the beginning: Manufacturing, assembly, suppliers, tooling, and inspection are development inputs, not post-design tasks.
• Verify continuously: Subsystem testing and early protocol development make failures easier to isolate and correct.
• Include users early: Human factors findings are most valuable before the interface and workflow are difficult to change.
• Document as you develop: Current traceability and design records support both speed and regulatory readiness.
• Use partners strategically: An experienced medical device engineering firm can close capability gaps and add leadership without requiring immediate full-time hiring.

Frequently asked questions

What is the fastest way for a medical device startup to reduce development time?

The fastest approach is usually to identify and resolve high-impact uncertainty early. Start with clear user needs, measurable requirements, preliminary risk analysis, focused prototypes, early manufacturing input, and a verification strategy that runs throughout development. Hiring more people without improving decision flow may increase activity without reducing rework.

Should a startup complete its quality system before beginning engineering?

A startup should establish the quality processes appropriate to its development stage before controlled design work begins. The system does not need to be unnecessarily complex, but it should define document control, design planning, design inputs and outputs, reviews, verification, validation, risk management, change control, supplier controls, and records. ISO 13485 is the internationally recognized quality management standard specific to medical device organizations. ([iso.org](https://www.iso.org/iso-13485-medical-devices.html?utm_source=openai))

How early should manufacturing engineers become involved?

Manufacturing input should begin during concept and architecture development, especially when the device includes custom tooling, high-volume disposables, tight tolerances, complex assembly, sterilization, packaging, or specialized suppliers. Early involvement can prevent designs that work technically but are difficult or expensive to produce consistently.

Why do medical device startups need systems engineering?

Systems engineering connects user needs, requirements, architecture, interfaces, risk controls, verification, validation, and change decisions. It helps prevent one subsystem from being optimized in a way that creates problems elsewhere in the device. This is especially important for electromechanical, fluidic, software-enabled, robotic, and combination systems.

Can outsourcing engineering really make a product launch faster?

Yes, when the external team has relevant medical device experience and integrates with the startup’s processes. An external partner can provide specialized expertise, program leadership, analytical capability, manufacturing support, quality support, or regulatory documentation without the time required to recruit and onboard a complete internal team. The engagement should include clear deliverables, decision rights, communication routines, and knowledge transfer.

How does human factors engineering affect the development schedule?

Early human factors work can shorten the schedule by exposing use-related problems before the device form, controls, labeling, and workflow are locked. Late usability findings may require changes to hardware, software, training, labeling, risk controls, and validation plans. FDA guidance emphasizes documenting human factors information using a risk-based approach for applicable marketing submissions. ([fda.gov](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions?utm_source=openai))

What should be included in an acceleration assessment?

An acceleration assessment should examine the product definition, intended use, requirements, architecture, risk file, prototype evidence, verification plan, human factors activities, manufacturing assumptions, supplier readiness, quality system, regulatory strategy, schedule dependencies, and open decisions. The output should identify the critical path, the most important unresolved risks, and the specific actions needed to move the program forward.

How can A65 Consulting help a medical device startup?

A65 Consulting provides medical device design, systems engineering, manufacturing engineering, program management, quality engineering, regulatory support, prototyping, analysis, verification planning, and manufacturing transfer assistance. Its team can supplement an existing organization or provide broader product development support from concept through launch. Contact A65 Consulting to discuss your development needs.

Next steps: turn schedule pressure into a structured plan

Medical device startups do not need to choose between speed and rigor. A disciplined development process can improve both. Begin by identifying the decisions that could create the most downstream rework, then connect those decisions to requirements, risks, prototypes, tests, users, suppliers, and production processes.

If your team is facing a capability gap, a difficult technical milestone, incomplete design documentation, or an approaching manufacturing transfer, contact A65 Consulting to schedule a discovery conversation. A65 Consulting helps medical device companies move from concept to viable, manufacturable products with integrated engineering and practical execution.

For additional medical device engineering perspectives, visit the A65 Consulting blog.